Search Results 201-210 of 6174 for albumin

  1. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

    Albumin > 3 mg/dl; Blood urea nitrogen (BUN) =< 30 mg/dl; Creatinine =< 1.7 mg/dl; The following imaging workup to document metastases within 45 days prior to ...

  2. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

    Albumin level ≥3.0 mg/dL or ≥ the lower limit of normal. 5. Renal: Serum creatinine ≤2 x ULN 13. Ability to take PO medication, be willing to adhere to ...

  3. Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations - Mayo Clinic

    Serum albumin ≥ 3.5 g/dL. Subjects with tumors potentially highly sensitive to tipifarnib (HRAS mutant VAF ≥35%) may be enrolled despite a serum albumin ...

  4. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Serum albumin ≥ 3.5 g/dL;; Serum potassium ≥ 3.5 mmol/L;; Fasting glucose ≤ 150 mg/dL (8.3 mmol/L) and hemoglobin A1c ≤ 7.5% (58 mmol/mol). Ability to ...

  5. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    Serum albumin <2.5 g/dL at baseline; CMV polymerase chain reaction (PCR) positive from blood plasma at screening; Known stool studies positive for ova and/or ...

  6. Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome - Mayo Clinic

    expansion with albumin. 7. Female patients as well as female partners of male patients must be willing to avoid pregnancy for the duration of the study (>90 ...

  7. A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer - Mayo Clinic

    Serum albumin ≥ 3.0 g/dL. Exclusion Criteria: Prior systemic treatment with androgen deprivation therapy and/or first-generation anti-androgen (e.g. ...

  8. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Patient must have adequate nutritional status with Body Mass Index (BMI) > 18 kg/m^2 and body weight of > 40 kg with serum albumin > 3 g/dL. Baseline ...

  9. Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    - Serum albumin ≥ 3.5 g/dL; - Serum Alkaline Phosphatase (ALP) ≤ 2 x ULN. - BMI ≥ 23 kg/m^2 at screening. Key Exclusion Criteria: - Prior history of ...

  10. Mayo Clinic

    00:00 / 00:00. Share · Tweet . VID-20207893. Home; Artificial Liver Ready for Human Testing - Bioartificial liver. Have 2X the impact!